Cybin Common Stock

Cybin (CYBN) currently reports a common stock of $350M as of September 2025. That compares with $440M in the prior-year period — down 20.3% year over year. Use the charts on this page to explore Cybin's common stock history and peer comparisons.

Cybin's common stock decreased from $440M to $350M — a 20.3% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cybin reported $350M in common stock as of September 2025. That compares with $440M in the prior-year period — down 20.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $350M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cybin, and consider following CYBN for alerts when major investors trade the stock.

Cybin is classified in the Healthcare sector. On common stock, it currently shows $350M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYBN with unrelated industries.